2023 Form 5500 filing — Cymabay Therapeutics, Inc. 401(K) Profit Sharing Plan And Trust

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240930132507NAL0009455520001) for Cymabay Therapeutics, Inc. 401(K) Profit Sharing Plan And Trust, reported by Cymabay Therapeutics, Inc. under EIN 94-3103561 and plan number 002. It reports 90 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

EFAST2 acknowledgement
20240930132507NAL0009455520001
Filing year
2023
Form type
2
Plan sponsor
Cymabay Therapeutics, Inc.
EIN
94-3103561
Plan number
002
Location
Newark, CA
Participants
90
Schedules available
Schedule I
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$16,271,149
Total liabilities (EOY)
$0
Net assets (EOY)
$16,271,149
Employer contributions
$217,700
Participant contributions
$1,512,712
Total income / additions
$5,246,357
Benefits paid
$590,349
Administrative expenses
$1,656
Total expenses
$598,395
Net increase / (decrease)
$4,647,962
Schedule source
Schedule I

Related Form 5500 pages